1. Academic Validation
  2. Brefeldin A enhances docetaxel-induced growth inhibition and apoptosis in prostate cancer cells in monolayer and 3D cultures

Brefeldin A enhances docetaxel-induced growth inhibition and apoptosis in prostate cancer cells in monolayer and 3D cultures

  • Bioorg Med Chem Lett. 2017 Jun 1;27(11):2286-2291. doi: 10.1016/j.bmcl.2017.04.047.
Huarong Huang 1 Ting Liu 2 Junxi Guo 2 Lin Yu 2 Xiaofeng Wu 2 Yan He 2 Dongli Li 3 Junlei Liu 2 Kun Zhang 2 Xi Zheng 4 Susan Goodin 5
Affiliations

Affiliations

  • 1 Allan H. Conney Laboratory for Anticancer Research, Guangdong University of Technology, Guangzhou 510006, China. Electronic address: hrhuang@gdut.edu.cn.
  • 2 Allan H. Conney Laboratory for Anticancer Research, Guangdong University of Technology, Guangzhou 510006, China.
  • 3 Department of Chemical Engineering and Environment, Wuyi University, Jiangmen 510060, China.
  • 4 Allan H. Conney Laboratory for Anticancer Research, Guangdong University of Technology, Guangzhou 510006, China; Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, United States. Electronic address: xizheng@pharmacy.rutgers.edu.
  • 5 Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, United States.
Abstract

Docetaxel is a commonly used chemotherapeutic drug for patients with late stage prostate Cancer. However, serious side effect and drug resistance limit its clinical success. Brefeldin A is a 16-membered macrolide Antibiotic from mangrove-derived Fungus Aspergillus sp. (9Hu), which exhibited potent cytotoxicity against human Cancer cells. In the present study, we determined the effect of brefeldin A on docetaxel-induced growth inhibition and Apoptosis in human prostate Cancer PC-3 cells. Brefeldin A in combination with docetaxel inhibited the growth of PC-3 cells in monolayer and in three dimensional cultures. The combination also potently stimulated Apoptosis in PC-3 cells as determined by propidium iodide staining and morphological assessment. Mechanistic studies showed that growth inhibition and Apoptosis in PC-3 cells treated with brefeldin A and docetaxel were associated with decrease in the level of Bcl-2. The present study indicates that combined brefeldin A with docetaxel may represent a novel approach for improving the efficacy of docetaxel, and Bcl-2 may serve as a target for brefeldin A to enhance the effects of docetaxel chemotherapy.

Keywords

3D culture; Bcl-2; Brefeldin A; Docetaxel; Prostate cancer.

Figures